Allergan: Cramer’s Top Takeaways

Did you miss last night’s “Mad Money” on CNBC ? If so, here are some of Jim Cramer’s top takeaways. In his third and final “Executive Decision” segment, Cramer spoke with Brent Saunders, chairman and CEO of Allergan , which today reported a 14-cents-a-share earnings beat on a 7% rise in revenues, but still trades at just 15 times earnings.